BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid Leukemia.
Ramsey HE, Greenwood D, Zhang S, Childress M, Arrate MP, Gorska AE, Fuller L, Zhao Y, Stengel K, Fischer MA, Stubbs MC, Liu PCC, Boyd K, Rathmell JC, Hiebert SW, Savona MR.
Ramsey HE, et al.
Clin Cancer Res. 2021 Jan 15;27(2):598-607. doi: 10.1158/1078-0432.CCR-20-1346. Epub 2020 Nov 4.
Clin Cancer Res. 2021.
PMID: 33148670